UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 126

Sortiert nach

Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection

Journal of hepatology, 2019-05, Vol.70 (5), p.1019-1023

2019

Link zum Volltext

Verfügbarkeit prüfen

Prognostic impact of steatosis in the clinical course of chronic HCV infection—Results from the German Hepatitis C-Registry

PloS one, 2022-06, Vol.17 (6), p.e0264741-e0264741

2022

Link zum Volltext

Verfügbarkeit prüfen

Effect of antiviral therapy for HCV on lipid levels

Antiviral therapy, 2017, Vol.21 (1), p.81-88

2017

Link zum Volltext

Verfügbarkeit prüfen

Real‐world effectiveness of sofosbuvir‐based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO‐03)

Journal of medical virology, 2018-02, Vol.90 (2), p.304-312

2018

Link zum Volltext

Verfügbarkeit prüfen

Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection

World journal of gastroenterology : WJG, 2014-08, Vol.20 (31), p.10984-10993

2014

Link zum Volltext

Verfügbarkeit prüfen

Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)

Biomedicines, 2021-10, Vol.9 (10), p.1495

2021

Link zum Volltext

Verfügbarkeit prüfen

Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C‐Registry

Hepatology communications, 2022-09, Vol.6 (9), p.2488-2495

2022

Link zum Volltext

Verfügbarkeit prüfen

Chronic hepatitis C： Treat or wait？ Medical decision making in clinical practice

World journal of gastroenterology : WJG, 2012-03, Vol.18 (12), p.1339-1347

Claus Niederau Dietrich Huppe EImar Zehnter Bernd Moiler, Renate Heyne Stefan Christensen Rainer Waft Arno Theilmeier Ulrich Alshuth Stefan Mauss

2012

Link zum Volltext

Verfügbarkeit prüfen

Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir

Hepatology (Baltimore, Md.), 2014-01, Vol.59 (1), p.46-48

2014

Link zum Volltext

Verfügbarkeit prüfen

A not so easy genotype—striking regional differences in SOF/RBV treatment responses in HCV GT2

Liver international, 2017-08, Vol.37 (8), p.1253-1254

2017

Link zum Volltext

Verfügbarkeit prüfen

A not so easy genotype—striking regional differences in SOF / RBV treatment responses in HCV GT 2

Liver international, 2017-08, Vol.37 (8), p.1253-1254

2017

Link zum Volltext

Verfügbarkeit prüfen

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs

Clinical infectious diseases, 2013-08, Vol.57 (suppl_2), p.S125-S128

2013

Link zum Volltext

Verfügbarkeit prüfen

Cystatin C as a marker of renal function is affected by HIV replication leading to an underestimation of kidney function in HIV patients

Antiviral therapy, 2008-01, Vol.13 (8), p.1091-1095

2008

Link zum Volltext

Verfügbarkeit prüfen

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

Journal of hepatology, 2017-11, Vol.67 (5), p.918-924

2017

Link zum Volltext

Verfügbarkeit prüfen

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

The New England journal of medicine, 2015-12, Vol.373 (27), p.2599-2607

2015

Link zum Volltext

Verfügbarkeit prüfen

Direct‐acting antiviral treatment of chronic HCV‐infected patients on opioid substitution therapy: Still a concern in clinical practice?

Addiction (Abingdon, England), 2018-05, Vol.113 (5), p.868-882

2018

Link zum Volltext

Verfügbarkeit prüfen

Prescription of new HCV-drugs - what has to be considered judicially

Zeitschrift fur Gastroenterologie, 2015-01, Vol.53 (1), p.43

Mauss, Stefan

2015

Link zum Volltext

Verfügbarkeit prüfen

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs: Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda Forward

Clinical infectious diseases, 2013, Vol.57

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials

Clinical infectious diseases, 2016-12, Vol.63 (11), p.1405-1411

2016

Link zum Volltext

Verfügbarkeit prüfen

Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era

Clinical infectious diseases, 2020-08, Vol.71 (5), p.1248-1254

2020

Link zum Volltext

Verfügbarkeit prüfen

Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C

Journal of hepatology, 2018-04, Vol.68 (4), p.663-671

2018

Link zum Volltext

Verfügbarkeit prüfen

Post-treatment elevated gamma-glutamyl transferase is the best predictor for future outcomes in HCV patients achieving sustained virological response-data from the german hepatitis C-registry (DHC-R)

Journal of hepatology, 2022-07, Vol.77, p.S562-S563

2022

Link zum Volltext

Verfügbarkeit prüfen

Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV–Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01)

Clinical infectious diseases, 2016-11, Vol.63 (10), p.1320-1324

2016

Link zum Volltext

Verfügbarkeit prüfen

Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study)

Clinical infectious diseases, 2023-02, Vol.76 (3), p.e607-e612

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 126

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

KollektionSpringerLink (Online service)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Englisch
(122)
Deutsch
(6)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(79)
Life Sciences & Biomedicine
(78)
Humans
(68)
Male
(49)
Female
(44)
Adult
(42)
Infectious Diseases
(42)
Middle Aged
(40)
Gastroenterology & Hepatology
(38)
Antiviral Agents - Therapeutic Use
(33)
Hepatitis C
(26)
Hepatitis C, Chronic - Drug Therapy
(24)
Hepatitis
(23)
Aged
(21)
Hepatitis C Virus
(20)
Biological And Medical Sciences
(19)
Drug Therapy, Combination
(18)
Human Immunodeficiency Virus
(18)
Medical Sciences
(18)
Treatment Outcome
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection

Comprehensive Analysis of Frequency and Phenotype of T Regulatory Cells in HIV Infection: CD39 Expression of FoxP3+ T Regulatory Cells Correlates with Progressive Disease

Prognostic impact of steatosis in the clinical course of chronic HCV infection—Results from the German Hepatitis C-Registry

Effect of antiviral therapy for HCV on lipid levels

Real‐world effectiveness of sofosbuvir‐based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO‐03)

Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection

Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)

Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C‐Registry

Chronic hepatitis C： Treat or wait？ Medical decision making in clinical practice

Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir

A not so easy genotype—striking regional differences in SOF/RBV treatment responses in HCV GT2

A not so easy genotype—striking regional differences in SOF / RBV treatment responses in HCV GT 2

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs

Cystatin C as a marker of renal function is affected by HIV replication leading to an underestimation of kidney function in HIV patients

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

Direct‐acting antiviral treatment of chronic HCV‐infected patients on opioid substitution therapy: Still a concern in clinical practice?

Prescription of new HCV-drugs - what has to be considered judicially

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs: Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda Forward

Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials

Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era

Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C

Post-treatment elevated gamma-glutamyl transferase is the best predictor for future outcomes in HCV patients achieving sustained virological response-data from the german hepatitis C-registry (DHC-R)

Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV–Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01)

Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study)

Aktive Filter

Suchergebnisse filtern